FierceBiotechOriginal article
{"a":[{"_":"FDA releases 14 new drug rejection letters after 3-month pause in transparency policy","$":{"href":"/biotech/fda-releases-14-new-drug-rejection-letters-after-transparency-policy-paused-april","hreflang":"en"}}]}
RegulatoryrejectedNegative
AI Analysis
Summary
The FDA released 14 new drug rejection letters after resuming a transparency policy that had been paused in April. No specific drug names, companies, or additional details were disclosed in the announcement.
Outcome Details
FDA published 14 new rejection letters for drug applications
Importance:4/10
Sentiment:
-0.60
FDAdrug rejectionsregulatorytransparency
Read the original article
Published by FierceBiotech on July 13, 2026 11:02 AM